Familial colorectal cancer.

Area of Science:

• Oncology
• Genetics
• Public Health

Background:

• Average-risk colorectal cancer (CRC) screening programs are expanding.
• Current definitions of familial CRC may not adequately identify individuals needing enhanced surveillance.
• Many individuals with a family history of CRC do not have well-defined inherited syndromes.

Purpose of the Study:

• To redefine

Main Methods:

• Review of existing literature on CRC screening and familial risk.
• Analysis of criteria for defining high-risk subgroups within familial CRC.
• Consideration of evolving screening technologies for genetic mutations.

Main Results:

• Two subgroups identified for intensive surveillance: those with ≥1 first-degree relative (FDR) with CRC diagnosed <50 years, and those with ≥2 FDRs with CRC.
• Colonoscopy at age 40 is a recommended screening strategy for these high-risk groups.
• Advancements in Lynch syndrome screening and genetic mutation analysis may improve classification.

Conclusions:

• The definition of familial CRC requires reconsideration to focus on individuals outside population-based screening benefits.
• Personalized surveillance strategies are crucial for high-risk familial CRC groups.
• Improved genetic screening tools can reduce misclassification and optimize cancer risk management.